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Executive Summary
During the last two decades, Nigeria’s Contraceptive Prevalence Rate (CPR) for modern methods
remained at 10% (NPC and ICF International 2014), one of the lowest rates in sub-Saharan Africa.
Following the renewed global commitments culminating in the 2012 London Summit on Family
Planning with promises to reach an additional 120 million new users of quality modern
contraceptives worldwide, Nigeria’s Federal Ministry of Health (FMoH) in collaboration with
reproductive health (RH) stakeholders set an ambitious new target of raising Nigeria’s CPR to 36% by
2018. One of the ways to accomplish this goal is by meeting the contraceptive needs of women in the
immediate postpartum period and beyond. Currently, unmet need for contraception in the
postpartum period is 65% as opposed to 16% for regular use (NPC and ICF International 2014).
Consequently, attention is being focused on making proven and effective contraceptive methods
more available and affordable for postpartum use by including in the methods newer technologies
that are breastfeeding-friendly. The Progesterone Vaginal Ring (PVR) holds much promise as an
effective family planning method specifically geared for breastfeeding women. For use beyond the
postpartum period, an investigational long-acting Contraceptive Vaginal Ring (CVR) is currently being
developed. As a prelude to introducing the rings in sub-Saharan Africa, the Population Council, with
funding from the Bill and Melinda Gates Foundation (BMGF) and the United States Agency for
International Development (USAID), conducted a “Willingness to Pay’ (WTP) study in Kenya, Nigeria,
and Senegal. In order to better understand how the rings could be placed within an equity framework
and achieve an optimized service environment, we ensured that both consumers’ and providers’
preferences, as well as procurers’ priorities, were factored into the introductory process. This
informed the conduct of this “Willingness to Pay, Provide, and Procure” exercise in these three subSaharan African countries.
Key findings from the study in Nigeria include:


Prospective consumers, providers, and procurers expressed support and interest in
contraceptive vaginal rings (CVRs). Frequently expressed opinions were that the PVR (and the
one-year CVR) are a welcome development that would add value to the postpartum family
planning landscape, widen contraceptive options for women, enhance child spacing, and
prevent unintended pregnancies.



Consumers are willing to pay for the PVR irrespective of the sector where they access their
contraceptive commodities. At a price point of US$1.70 (N300), more than 75% of
consumers are willing to pay for the PVR in the public, private nonprofit, and commercial
sectors. In the public sector, willingness to pay declines at prices over N300. However, in the
private sector (nonprofit and commercial), a significant proportion of women are willing to
purchase the PVR at higher prices.
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Although the price of the PVR is a determinant of consumer demand, respondents also
indicated other factors such as the desire to avoid unintended pregnancy and the ability to
use modern contraceptives as being important to their decision-making. The importance of
wanting to avoid unwanted pregnancy is clearly reflected in the market as evidenced by the
high median cost of emergency contraceptive (EC) pills (US$27) in the private sector.



Consumers were willing to pay for the one-year CVR as well. The analysis indicates a feasible
price point of US$9 (N1,500) with a demonstrated willingness to pay across all three sectors.
At this price, over 65% are willing to pay in the public sector and over 80% in the private
nonprofit and commercial sectors.



The potential for innovative pricing mechanisms, especially for public-sector consumers, will
need to be explored. The mechanism would leverage existing government subsidies so that
consumers pay a small portion of the price with financing covering the rest.



Providers across all three sectors indicated the importance of including the PVR and the oneyear CVR in the method mix. Their responses also highlighted the importance of orientation
and education of potential providers to ensure their successful integration when eventually
registered.



The procurement, pricing, and quality assurance systems are robust in Nigeria. The PVR (and
the one-year CVR), when introduced, could easily feed into the existing structures and obviate
the need for establishing parallel procurement, pricing, and quality assurance systems for the
PVR and the one-year CVR.

In terms of utilization, the results generated will inform and guide next steps about product
introduction. Specifically, the findings of this study will be integrated with results from a market
segmentation exercise conducted earlier to develop a pricing model for the PVR. The price will reflect
not only the cost of goods (COGS) and cost of product introduction (training, educational material,
marketing and branding, demand creation) but also the benefits to the health system (e.g., limited
need for infrastructure and equipment, potential for multiple service outlets and health cadres). The
results will also be useful to refine PVR market segmentation and tailor specific strategies for product
introduction, including innovative financing approaches.

2

Introduction
During the last two decades, the contraceptive prevalence rate (CPR) for modern methods has
remained at 10% in Nigeria (NPC and ICF International 2014), one of the lowest rates in sub-Saharan
Africa. Following the renewed global commitments culminating in the 2012 London Summit on Family
Planning,1 which aims at reaching an additional 120 million new users with quality modern
contraceptive methods by the year 2020, the Federal Ministry of Health (FMoH) in collaboration with
reproductive health stakeholders in Nigeria unveiled the Nigeria Family Planning Blueprint with an
ambitious new target of raising the contraceptive prevalence rate to 36% by 2018.2 This scale-up
plan will help avert 1.6 million unintended pregnancies, as well as 400,000 infant and 700,000 child
deaths, by the year 2018 at an estimated cost of US$603 million.
An integral part of this commitment involves meeting the contraceptive needs of women in the
immediate postpartum period and beyond with the help of expanded social marketing services.
Currently, the unmet need for contraception in the postpartum period is 65% as opposed to 16% for
regular use (NPC and ICF International 2014). Consequently, attention is now being focused on
making available and accessible proven effective contraceptives for postpartum use. Contraceptive
Vaginal Rings (CVRs), as a new product category, hold a lot of potential as an effective family planning
method for women throughout their reproductive health life cycle. As a self-initiated method that does
not require daily action by the user or significant health system infrastructure for service delivery,
vaginal rings can be a great addition to the existing method mix for modern contraception.
The Progesterone Vaginal Ring (PVR) is designed exclusively for addressing the postpartum family
planning needs of breastfeeding women. While the PVR is already being used by women in nine
countries in Latin America, women in sub-Saharan Africa, where breastfeeding is almost universal,
have no access to this technology. To expand access in this region, the Population Council, with
funding from the Bill & Melinda Gates Foundation (BMGF) and the United States Agency for
International Development (USAID), conducted various pre-introductory activities in sub-Saharan
Africa where women practice prolonged lactation and also have a high unmet need for postpartum
family planning of up to 65% in many countries (Sonalkar et al. 2013). The assessment of
“Willingness to Pay” (WTP) for the PVR was conducted to understand economic factors that may
determine its uptake and use. In the case of contraceptives, WTP informs about the value that
people attach to the benefits of various contraceptives, especially their willingness and intentions
to purchase these contraceptives at various hypothetical prices. The study provides new
knowledge on the maximum amount of money that consumers are willing to spend for the PVR
and a related ring, the one-year CVR, from various service sectors (public, private nonprofit, and
private commercial).
Currently, Nigerian women obtain their contraceptive methods from both the public and private
sectors (nonprofit and commercial). A range of methods, including intrauterine contraceptive devices
(IUDs), implants, injectables, surgical tubal occlusion, and vasectomy are available for postpartum
use through Nigeria’s family planning policy. However, while contraceptive products are free in the
public sector (with minimum allowable fees charged to cover for the costs of consumables), they are

1
2

FP2020: http://progress.familyplanning2020.org/
Health Policy Project, Nigeria Family Planning Blueprint (Scale-Up Plan): http://www.healthpolicyproject.com/index.cfm?ID=topics-FP2020.
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not free in the private sector, which provides 60% of contraceptive services in the country (NPC and
ICF International 2014). Ever-increasing changes in the funding landscape have prompted
governments to explore “total market” solutions. The Total Market Approach (TMA) identifies specific
roles for the public and private sectors to meet the family planning needs of the population.
Specifically, the TMA focuses on ensuring that free or subsidized contraceptives are available to the
needy and poor, while social marketing channels and other private commercial sales of
contraceptives cater to those who are able to pay. This approach can help ensure equity and
sustainability of products and services over time and also manage funding shortfalls. Although
contraceptive commodities are free of charge in the public sector, commodity stock-outs are frequent
and so the private sector plays a dominant role in meeting women’s contraceptive needs.
The Nigeria Family Planning Blueprint includes strategies on service delivery, supply-chain
management, demand generation and behavior-change communications, and financing. By
investigating consumers’ willingness to pay for the ring, providers’ willingness to provide, and
procurers’ willingness to procure the ring in the three sectors that serve the total reproductive health
market in Nigeria, this study can inform programmatic interventions to contribute to these strategies.
A previously concluded market-segmentation exercise for vaginal rings provides us with the
knowledge of the various customer segments we will be serving when we introduce vaginal rings into
Nigeria’s family planning (FP) method mix. By matching different types of providers and services with
their appropriate target segments, we can promote effective intersectoral coordination and help the
Nigerian government better allocate resources to meet its FP2020 goals and beyond. In the PVR
introduction pathway, this study offers a reliable way of making evidence-based pricing decisions for
a new FP product and designing programs to achieve a total market solution for balancing the scales
of sustainability and cost recovery.
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Setting
COUNTRY ECONOMIC CONTEXT
Although Nigeria now has the largest economy in Africa based on its current GDP (Africa Progress
Panel 2015), the poverty rate in the country is one of the highest in the region with up to 61% of the
population living on less than US$1 per day (NBS 2012). Categorized as a lower-middle-income
economy, Nigeria is driven almost entirely by its thriving petroleum sector, which is the twelfth largest
in the world. More than 90% of foreign exchange earnings come from petroleum products, while the
rest of the economy is mostly agrarian. The recent fall in the price of oil in the international market
has implications for public expenditures on social welfare programs including health. Nigeria has
been growing at 6–8% annually over the past decade but now needs to achieve even higher job-led
growth rates to make a dent in poverty. A key challenge facing Nigeria is the diversification of its
economy and the reduction of heavy reliance on oil, which makes the country vulnerable to
commodity price volatility. However, Nigeria’s short-term economic outlook has improved in 2014 and
growing government revenues indicate macroeconomic stability and positive growth prospects.
Recent World Bank assessments highlight the decline in poverty levels; poverty is much lower in
urban areas (12.6%) than in rural areas (44.9%).3 After a minor slump in 2012, GDP growth
increased from 5.5% in 2013 to 6.3% in 2014. Inflation has remained on a downward trend since
2011 with the Consumer Price Index (CPI) inflation rate falling within the 8% range. While the
unemployment rate is about 10%4 and scarcity of jobs continues to be an economic problem, rapid
urbanization leading to higher connectivity with larger markets is having a positive impact on the
economy.
As of 2014, the per capita household final consumption expenditure (the market value of all goods
and services, including durable products such as cars, washing machines, and home computers
purchased by households) in Nigeria is on an upward trend reaching US$6165 and the gross national
income per capita remains stable at around US$2,970 (current US$). In 2013, expenditure on private
health was 2.8 % of GDP, which includes direct household (out-of-pocket) spending, private
insurance, and charitable donations by private corporations, increasing from 2.3% in 2012. Public
health expenditure6 was 1.1% of GDP in 2013 and has remained at this level since 2011. Total
health expenditure7 has risen steadily from 3.4% of GDP in 2012 to 3.9% in 2013.
As Nigeria has a three-tier system of government (federal, state, and local) with different revenue
bases, there is potential for program priorities to differ between the three levels of administration
with implications for how social programs are planned and implemented. This may affect
harmonization of social investment including procurement of reproductive health and family planning
commodities especially for the public sector.

3

World Bank: Nigeria Economic Report (www.worldbank.org).
The internationally accepted ILO definition of unemployment includes members of the active labor population who are looking for work and are
available for work, but who are not working, during a previous reference period (often one week).
5 Data reported in constant 2005 US dollars. Source: World Bank national accounts data, and OECD national accounts data files.
6 Public health expenditure consists of recurrent and capital spending from government (central and local) budgets, external borrowings and
grants (including donations from international agencies and nongovernmental organizations), and social (or compulsory) health insurance funds.
7 Total health expenditure is the sum of public and private health expenditure. It covers the provision of health services (preventive and curative),
family planning activities, nutrition activities, and emergency aid designated for health, but does not include provision of water and sanitation.
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TABLE 1 Cost of living snapshot in Abuja, Nigeria
Commodity

Quantity

Average Price (US$)

Milk

1 gallon

6.7

Bread

1 pound

1.4

Eggs

1 dozen

2.0

Onions

1 pound

1.1

Beef

1 pound

2.1

Gasoline

1 gallon

1.7

Source: www.numbeo.com.

COUNTRY FAMILY PLANNING FINANCING CONTEXT
In Nigeria, family planning financing was entirely donor-driven until 2011 when the Federal
Government of Nigeria committed to providing US$3 million annually from 2011 to 2015 for
procurement of contraceptives for the public sector. Following the London summit in 2012, the
Nigerian government made a further pledge of providing an additional US$8.3 million for the same
reasons. The United Nations Population Fund (UNFPA) is the leading procurer of contraceptives for
the public sector, while USAID and the United Kingdom Department for International Development
(DfID) provide support for the private sector (Tien et al. 2009).
Investments from other development partners play a supplementary role. For example, from 2009 to
2015, BMGF invested in providing contraceptives (oral contraceptives, injectables, implants,
intrauterine devices) and services in urban areas through its Urban Reproductive Health Initiative
(URHI), which was recently renewed. URHI addresses challenges on the supply and demand side of
contraceptive use. The Society for Family Health (SFH) and DKT International8 are the leading social
franchising organizations that distribute reproductive health commodities in the private sector at
subsidized prices, thus serving a market segment that has limited ability to pay for services/products.
Available methods for postpartum women include injectables, condoms, progestin-only pills, and the
lactational amenorrhea method (LAM), with LAM being the most commonly used during this period
(Borda and Winfrey 2010). Data from the Nigeria DHS 2013 suggests that the major sources of
modern contraceptive methods for women are private health facilities, which supply 60%, followed by
public facilities at 29%.
Within the public sector, all contraceptives are offered free of charge by policy, but commodity stockouts are a frequent problem. This, coupled with service-fees, limits the utility of this policy because
methods are either not available or service fees are prohibitive. Consequently, a majority of users
obtain their contraceptives from the private sector at open market prices. The median cost of modern
contraceptives for women who paid for the last method they obtained ranged from about US$62 for
surgical contraception to less than US$1 each for pills and male condoms (NPC and ICF Macro
2009). The active role played by both the private and public sector in providing family planning
services indicates the potential for utilizing a total market solution for PVR introduction.

8

DKT International is a social marketing organization named after Deep K. Tyagi, Assistant Commissioner of Family Planning in charge of the
public motivation and education aspects of India’s Family Planning Program.
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Study Objectives
The objectives of this study are as follows:


Obtain a reliable estimate of consumers’ demand for the PVR in Nigeria by studying the effect
of price on demand;



Assess the “Willingness to Provide” by family planning providers and “Willingness to Procure”
by procurers;



Facilitate evidence-based pricing for the PVR in the three sectors of interest—public, private
nonprofit, and private commercial; and



Explore respondents’ Willingness to Pay for future vaginal rings (including long-acting,
reversible options for nonbreastfeeding women) to assess potential demand and to design
access strategies.

STUDY DESIGN AND METHODOLOGY
A cross-sectional study was conducted in three countries in sub-Saharan Africa (Kenya, Nigeria, and
Senegal). The study used a multidimensional and multisectoral approach, which examined the
willingness to pay for the PVR in the three countries.
Stakeholder-driven approach to WTP: In this approach (see Figure 1), we identified three actors in
the PVR WTP assessment landscape: potential consumers, providers, and procurers. We explored the
three dimensions of WTP (Willingness to Pay, Willingness to Provide, and Willingness to Procure) by
incorporating the voices of these three stakeholders in the data-collection tools.
Sector-driven approach to WTP: Using the guiding principles of improved access, efficient use of
public resources, and increased equity, we explored a potential total market model for the PVR by
exploring the views and expectations of different sectors that serve the family planning customers—
the public, private nonprofit, and private commercial sectors.
A previously conducted market-segmentation exercise based on DHS data revealed three broad
segments of potential PVR customers (Obare et al. 2014). Based on the analysis of the
socioeconomic profiles of these segments, the first segment denoted as “Easy Switchers” (urban,
educated women from rich households) presents the group with potentially the highest WTP, while
the other two segments—“Remote First-Timers” (rural, poorly educated women from the poorest
households) and “Growth Feeders” (young women with a future need for the PVR)—present potentially
decreasing levels of WTP. By utilizing a stakeholder-driven multisectoral approach to assess users’
WTP, this study will help develop affordable yet competitive pricing strategies for the PVR. The aim of
a TMA is to improve the performance of health systems by delivering the highest degree of
effectiveness, equity, and efficiency with the help of coordinated activities across the three sources of
supply. The study findings will help us formulate distribution strategies to match the potential PVR
consumer segments to the sectors that can best serve them, adopting a total market model.
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FIGURE 1 THREE DIMENSIONS OF WTP FOR THE PVR—WILLINGNESS TO PAY, PROVIDE,
AND PROCURE

Consumers
WT PAY

Providers
WT PROVIDE

Procurers
WT PROCURE

PVR WTP

Availability and
Access

Service Delivery

Demand

SURVEY INSTRUMENTS
Specific survey instruments were designed for targeted respondents. Table 2 summarizes the survey
tools and methodology used.
TABLE 2 Study design, methodology, and scope
Stakeholder

Survey Instrument

Target Respondents

Consumers

a) WT Pay Survey
b) Price-Tracking
Survey

a) Potential consumers (women 18–49 years of age)
b) Pharmacists; facilities in charge at socialmarketing outlets; public FP clinics

Providers

WT Provide Survey

FP service providers and members of professional
associations, such as pharmacists, ob/gyns,
midwives, nurses, other providers

Procurers

WT Procure Survey

MoH, UNFPA, USAID Mission, and large
pharmaceutical distributors

a) Price-Tracking Survey: In this survey, adapted from the price-tracking survey manual
designed by the World Health Organization (WHO) and Health Action International (HAI),9
we tracked the real prices paid by women for family planning services/products in the
three sectors: public, private nonprofit, and private commercial. This survey consisted of
interviews with staff in facilities that were responsible for FP commodities management
to get a snapshot of the pricing landscape of contraceptives currently sold in-country and
to estimate the “Affordability” of the product and the “Ability to Pay” of potential PVR
consumers to enable competitive pricing of the PVR. The respondents included those in
charge of selected health facilities, including pharmacies and social-marketing outlets. A
total of 62 health facilities were assessed in this survey, 17 from the private nonprofit
sector and 45 from the private commercial sector.

9

WHO/HAI: http://www.haiweb.org/medicineprices.
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b) WT Pay Survey (Consumer Survey): Consisted of interviews with potential PVR consumers
directly to estimate the potential number of women who will pay a given price for the PVR
and the characteristics of the individuals who will or will not pay that price. Exit interviews
were conducted with women as they left facilities where FP services were offered.
Respondents were shown a product sample and provided with a detailed description
(use/benefits) of the PVR. Respondent interest was ascertained (by providing an option
to rate their interest in the PVR before starting the survey) and uninterested respondents
were not interviewed after recording the reason for their lack of interest. Questions
focused on PVR pricing following a bidding game model based on the Contingent
Valuation methodology as shown in Figure 3 (Foreit and Foreit 2001). Questions started
with a modest PVR starter price, which was pegged at US$1.70 (N300) in all three
sectors.10 The series of questions assume a 10% increase in price and subsequently a
higher or lower increase based on the participant’s response. We ended the interview
with two open-ended questions: (1) We asked about the maximum price the participant
was willing to pay for the PVR independent of the previously mentioned prices; and (2)
We sought to know the possible action the respondent would take if the price was found
to be too high. Survey respondents included 400 urban and peri-urban women aged 18
and above seeking family planning services at selected health facilities in Abuja. The
number was distributed as follows: public (229); private nonprofit (80), and private
commercial (91), following a stratified sampling strategy.
c) WT Provide Survey: For providers, a “WT Provide Survey” was conducted. Family planning
service providers in selected health facilities were aged 18 years and above. We
interviewed a total of 50 providers—public (14), private nonprofit (3), and private
commercial (33) sectors. The providers were asked qualitative questions to gauge their
willingness to provide the PVR as part of the existing FP method mix in their health
facilities. In addition, they were asked to estimate the maximum amount that should be
charged (if any) for providing the PVR. Respondents included randomly selected FP
providers such as gynecologists, nurses and matrons, pharmacists, and community
health workers.
d) WT Procure Survey: For the procurers, a “WT Procure Survey” was conducted and
included representatives of government, and of social marketing and donor agencies
involved in procuring FP commodities. A total of 19 procurers were interviewed.
Procurers were asked to provide the price list of procured FP commodities and their
assessment of a reasonable price estimate for procuring the PVR, to assess their
willingness to procure it.

10

US$1.70 (N300) is the mean price of 3-month injectable contraceptives in Nigeria; there are marginal variations in price within the private
sector (nonprofit versus commercial). FP commodities in the public sector are free, but we still used the starter price to determine WTP as this
would serve as a realistic starter price for a public-sector client if the product were not available in the public sector.
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FIGURE 2 CONSUMER SURVEY: BIDDING-GAME MODEL
Q1

Q2

Q3

Q4

Q5

Maximum WTP
(independently)

What would
you do if
the price
was too
high?

Higher increase
(fixed)

Starter
price
(fixed)
Price of a
3-month
injectable

Price after 20%
increase

Moderate
increase
(fixed)
Price after
10% increase

Lower increase
(fixed)
Price after 5%
increase

Source: Foreit and Foreit. 2001. “Willingness to pay surveys for setting prices for reproductive health products and services: A user’s manual.”
Frontiers in Reproductive Health, Population council, Policy Project, and Futures Group International.

IMPLEMENTATION
Ethics clearance: The Federal Capital Territory Health Research Ethics Committee (FCTHREC) granted
ethical clearance for the study. Informed consent was obtained from all participants. Anonymity of
participants and confidentiality of the information provided was ensured.
Site selection: The Federal Capital Territory (FCT) of Abuja, Nigeria’s capital city, was selected for the
surveys because it provides a fair representation of the key population groups. Public family-planning
centers and service-delivery facilities run by nonprofit organizations within and around the federal
capital were also selected. Last, private commercial facilities were selected based on the availability
of skilled providers and clients’ volume at those facilities.
Training of data collectors: Training followed a systematic process that ensured data collectors’
effectiveness during the actual fieldwork. In the first phase of this process, a cascaded training model
was used to train data collectors on the survey process, data-collection instruments, and the ethical
conduct of the study. Survey tools were pretested and suggested modifications were incorporated
prior to study implementation. All the data collectors participating in the study had previous
experience conducting surveys in this setting.
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Results
PRICE-TRACKING SURVEY
Intersectoral Price Comparisons
Table 3 shows the median prices of
TABLE 3 Median prices of commonly available
various contraceptives in the private
contraceptives by sector 11
nonprofit versus private commercial
Private Nonprofit
Private Commercial
Contraceptive
sectors. Tracking prices across these
Sector (Naira)
Sector (Naira)
sectors provides useful information for
Injectables
200
438
tailoring affordable pricing strategies
Male Condoms
188
315
for the PVR given its utility and
Female Condoms
300
—
comparative advantages. As FP
Combined Pills
300
100
commodities are free in Nigeria’s public EC Pills
300
4,300
facilities, this sector was not tracked.
Implanon (1 rod)
200
3,000
As shown in Table 3, injectable
Jadelle (2 rods)
—
3,000
contraceptives (which are progestinCopper IUD
450
2,000
only and administered every three
®
LNG-IUS (Mirena )
1,000
—
months like the PVR) are sold at the
— = Price not available.
median prices of US$2.70 (N438) and
(US$1.30) N200 in the private commercial and private nonprofit sectors, respectively. EC pills have
the highest median price of approximately US$27 (N4,300) in the private commercial sector, which
may indicate how much women are willing to spend to prevent unintended pregnancies. The
Levonorgestrel Intrauterine System (LNG-IUS) is typically very expensive (ranging from N1,000–
N8,000 or US$6–$50 if found in private clinics), but is mostly offered free of charge in private
nonprofit outlets (with a minimal service fee of N1,000) through a donation from the International
Contraceptive Access Foundation (ICAF). In general, median prices for contraceptive commodities are
higher in the private commercial sector than the nonprofit sector, as should be expected.

Method Availability by Sector
A wide variety of contraceptives are available in the three sectors; injectables and pills are the most
popular among consumers, next to male condoms. Across the three sectors, the injectable Noristerat
and the emergency contraceptive pill Postinor 2 are the most popular brands. Other commonly
available brands include Gold Circle (male condoms), Depo Provera (injectable), Copper T (IUD),
Jadelle (implant), and combined oral contraceptives. Respondents indicated that stocks are
replenished on a monthly basis for the most popular methods in their facilities.

11

At the time of the survey, US$1 = N160.
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CONSUMER SURVEY
Sector Demographics
As depicted in Table 4, of the 400 consumers surveyed, 229, 80, and 91 were from the public,
private nonprofit, and private commercial sectors, respectively. In all the sectors, the majority of
respondents fell between the ages of 25 and 39 corresponding to the ages for peak fertility in
Nigeria. Similarly, over 80% of the surveyed consumers completed secondary or college education,
indicating a highly educated population of women. In this sample, the proportion of respondents who
had no education was low whether they were in the public (0.9%) or private nonprofit (1.3%) sectors.
The majority of the respondents have 1–3 children with 61%, 51%, and 58% of women from the
public, private nonprofit, and private commercial sectors, respectively, falling in this category. About
20% of respondents across the three sectors have no children, and 1.7% of women have more than 5
children as compared to the total fertility rate (TFR) of 5.5 in the country (NPC and ICF International
2014). Overall, the consumers who participated in this study are representative of the urban rich
profile, with higher social status and presumably higher levels of ability to pay.
TABLE 4 Sociodemographic characteristics of study participants by sector
Variable

Public Sector

Private Nonprofit Sector

Private Commercial Sector

N=229

%

N=80

%

N=91

%

15–19

6

3

0

0

1

1

20–24

31

14

3

4

9

10

25–29

67

29

27

34

27

30

30–34

54

24

25

31

25

28

71

31

23

28

27

29

Age

>35
Education
Primary

19

8

3

4

5

27

Secondary

94

41

20

25

24

26

College

93

41

47

59

51

56

None

2

1

1

1

0

0

None

33

14

20

25

23

25

1–3

139

61

41

51

53

58

4–5

48

21

10

13

13

14

>5

6

3

1

1

1

1

Yes

213

93

68

85

76

84

No

15

7

11

14

15

17

Yes, currently use

83

36

21

26

25

28

Yes, intend to use in future

146

64

55

69

66

73

Number of children

Marital status

FP use/intent

Almost all of the respondents were either currently using a contraceptive method or intended to use
one in the future. This may in part reflect the study design and the future contraceptive demand in
the country, at least for women in urban and peri-urban settings where this study took place.
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Socioeconomic Characteristics of Study Participants by Sector
TABLE 5 Socioeconomic characteristics of study participants by sector
Variable

Public Sector
n=229

Occupation
Housewife/not working

Private Nonprofit Sector
%

n=80

%

Private Commercial Sector
n=91

%

48

21

15

19

11

12

Retail

31

14

11

14

15

17

Wholesale trade

17

7

1

1

4

4

Agriculture/livestock

2

1

0

0

2

2

Private work

27

12

31

39

42

46

Government work

69

30

9

11

9

10

Manual work

17

7

6

8

2

2

Partner’s Occupation
Not working

2

1

0

0

1

1

Retail

5

2

1

1

1

1

Wholesale trade

9

4

1

1

10

11

Agriculture/livestock

4

2

1

1

3

3

Private work

63

28

28

35

28

31

Government work

74

32

22

28

17

19

Manual work

28

12

6

8

5

6

Household Items
Television

215

94

79

99

89

98

Refrigerator

169

74

70

88

74

81

Vehicle

115

50

45

56

39

43

Mobile

221

97

80

100

87

96

Radio

195

85

70

88

80

88

Salon Visits
Weekly

53

23

17

21

15

17

Two weeks/biweekly

35

15

16

20

12

13

Monthly

103

45

38

48

49

54

Does not visit

29

13

7

9

8

9

15

7

1

1

4

4

10,001–50,000

69

30

20

25

30

33

>50,000

69

30

29

36

29

32

No response/Does not know

76

33

30

38

28

31

Monthly Expenses (Naira)
1,000–10,000

Monthly Income (Naira)
1,000–10,000

24

11

1

1

9

10

>10,000–50,000

95

42

29

36

31

34

>50,000

60

27

24

31

26

29

No response/Does not know

50

22

26

33

25

28

Monthly FP Expense (Naira)
1,000–10,000

9

4

1

1

2

2

>10,000–50,000

28

13

10

13

12

13

>50,000

7

7

4

4

6

6

185

81

66

83

71

78

No response/Does not know
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Table 5 depicts the socioeconomic characteristics of the respondents. More than 80% of the
consumers surveyed were gainfully employed. This nearly mirrors the Nigeria Demographic and
Health Survey 2013, which indicates that more than 70% of Nigerian women were employed, with 7
out of 10 of the employed women able to make independent decisions on how they spend their
earnings. The majority of the women reported household monthly incomes of between N10,000
(US$63) and N100,000 (US$625), with about 16% reporting more than N100,000 per month.
More than half of the women (59%) across the three sectors visit a hair salon on a monthly basis,
whereas 20% visit on a weekly basis. Although most of the respondents did not disclose their monthly
expenditure for family planning services, the high employment rate and the average monthly income
of the respondents suggest a population with high purchasing power, increasing the potential for
consumers to purchase the PVR. Across the three sectors, 13% of respondents indicated that they
spent between N10,000 (approximately US$63) and N50,000 (approximately US$313) on their
family planning needs. The frequency of hair salon visits among consumers in this study suggests the
availability of discretionary income; however, the extent to which decisions on discretionary expenses
are made will depend on the range of needs that women may have and the priority they give to
reproductive health and FP services.

WTP for the PVR by Level of Increments and Sector
Table 6 shows that over 95% of respondents were interested in the PVR and participated in the
bidding game. Consumers responded to hypothetical increases in the price of the PVR starting from a
fixed price of N300 (approximately US$2), which is the median cost of injectable contraceptives that
are also administered every three months. More than 89% of respondents surveyed in the public
sector (195), 90% in the private nonprofit sector (70), and 94% in the private commercial sector (85)
were willing to buy the PVR at the starting price. This shows that most women who use all the sectors
are willing to purchase the commodity at a price comparable to the cost of injectable contraceptives,
with increasing tendency to do so moving from the public to private commercial sector. The same
pattern of higher willingness to pay in the private compared to the public sector continues with
increases in the price of the PVR by 10% and 20%. For example, when the starter price was increased
by 20%, although there was a decline in the willingness to pay across all the three sectors, those in
the private nonprofit (74%) and private commercial (83%) sectors were more willing to purchase the
PVR than those in the public sector (71%).
TABLE 6 WTP for the PVR by level of increments and sector
Variable

Private Nonprofit Sector
(n=80)

Public Sector (n=229)
%

Private Commercial Sector
(n=91)

%

%

Respondents interested in PVR

218

95

78

98

90

99

Starter price

195

89

70

90

85

94

10% increment

170

78

64

82

80

89

20% increment

154

71

58

74

75

83

For the PVR, over 85% of respondents interested in the method across the board indicated that they
will pay an additional 5% over their maximum WTP amount if it would help widen FP access to women
in low-resource settings. This altruistic willingness to pay is over 93% among respondents who access
the private commercial sector for contraceptive services (as shown in Table 7).
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TABLE 7

Altruistic WTP for the PVR by sector

Altruistic WTP (WTP 5% over
maximum stated amount if
used to help other women)

Public Sector

Private Nonprofit Sector

Private Commercial
Sector

n=229

%

n=80

%

n=91

%

Yes

195

85

70

87

85

93

No

31

14

10

13

6

7

Does not know

3

1

0

0

0

0

Sector Demand Curve
Figure 3 shows the PVR demand curve from the public sector consumers. In this sector, the
willingness to pay for the PVR is plotted against a range of incremental hypothetical prices in order to
gauge the value consumers place on the ring. It is clear that the demand falls with increasing price—
there is a considerable decline in WTP from N200 or US$1 (76%) to N300 or US$2 (31%) and it
continues to fall until N600 or US$4 at which only 5% of the women were willing to pay for the ring.
However, it is important to note that contraceptive commodities are free of charge in the public
health system across Nigeria and this category of consumers are accustomed to receiving
commodities free of charge. Given this knowledge, we can conservatively assert that consumers
within the public sector place high value on the ring, as up to 76% of them would still have a demand
for the ring at a price of N200 (US$1) which is equivalent to the price of a pound of onions in Abuja.

FIGURE 3 CONSUMER DEMAND CURVE FOR PVR—PUBLIC SECTOR
% respondents WTP
120
100% 99%

Demand (%WTP)

100
80

76%

60
40
20

31%
17% 16%
5%

4%

4%

0

n=229

Maximum Price (Naira)

15

2%

2%

0%

In contrast, the demand curve for consumers who obtain services through the private nonprofit sector
showed different demand outcomes, as depicted in Figure 4. In this case, at a price of N200, the
demand for the PVR is still high at 90%. Thereafter, there is a sharp decline in the demand curve, with
32% willing to pay for the ring at N500 (US$3). The demand curve for consumers who obtain their
services from the private commercial sector is similar; demand for the PVR is at 93% when the price
of the PVR is at N200 and declines thereafter (as shown in Figure 5).

FIGURE 4 CONSUMER DEMAND CURVE FOR PVR—PRIVATE NONPROFIT SECTOR
% respondents WTP
120

100% 99%

Demand (%WTP)

100

90%

80
56%

60

32% 32%

40

11%

20

11%

5%

4%

3%

1%

0%

0

Maximum Price (Naira)

n=80

The inflection point in the demand curve occurs around the N600 for the private sectors, although
there is robust demand at prices above that as well. For the public sector, the inflection point is at
prices close to approximately N500.

FIGURE 5 CONSUMER DEMAND CURVE FOR PVR—PRIVATE COMMERICAL SECTOR
% respondents WTP
120

Demand (%WTP)

100

100% 100%

93%

80
58%
60
40
20

28% 24%
11% 11% 10%

0

n=91

Maximum Price (Naira)

16

10%

2%

1%

1%

0%

In addition to analyzing the economic aspects of decision-making, we also examined other reasons
why consumers would be willing to pay for the ring. Figure 6 displays the relative contributions of
other determinants of demand across the public, private nonprofit, and private commercial sectors,
respectively. As the figure depicts, the price of the ring is a very important consideration for
consumers across all sectors, but the relative contribution of price progressively diminishes from the
public to the private sector. For example, while 54% of public sector consumers would purchase the
ring because the price is perceived to be affordable, fewer consumers in the private nonprofit (36%)
and private commercial (37%) sectors, respectively, would make purchase decisions based on the
price.
The next important consideration in women’s demand for the ring is fear of the economic
consequences of unintended pregnancy, leading to higher expenses. The relative value of this
determinant varies from sector to sector. Fear of unintended pregnancy as a determinant of demand
is highest among consumers in the private nonprofit sector (31%), followed by the private commercial
sector (27%), and last, the public sector (24%).

FIGURE 6 REASONS FOR WTP FOR THE PVR BY SECTOR
100%
80%
%

60%

54%

40%
20%

5%

12%

24%

36%

23%

31%

3%

37%

27%
13% 13%

0%
Public (n=229)

Private Nonprofit (n=80)

Private Commercial (n=91)

Sector
Price is affordable
Want to follow the recommendation of providers
I like/want the postpartum FP method
Unintended pregnancy might lead to high expenses

The next most important determinant as reported by consumers is the desire for an effective family
planning method during the postpartum period, with 23%, 13%, and 12% of private nonprofit, private
commercial, and public sector consumers, respectively, willing to pay for the ring on this account.
(See Figure 6.) Other reasons include recommendations of health service providers and other
nonspecific considerations. What this implies is that women, irrespective of where they receive their
contraceptive services, are not motivated only by one factor such as the price of the method alone.
The motivation for demand for a given product/service varies from one woman to another depending
on the prevailing socioeconomic circumstances, but the price is an important general consideration.
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TABLE 8 WTP for the one-year CVR by level of increments and sector
Variable

Public Sector

Private Nonprofit Sector

Private Commercial Sector

n=229

%

n=80

%

n=91

%

Starter price

145

65

60

77

66

75

10% increment

119

54

52

67

55

63

20% increment

98

45

43

55

48

55

Respondents interested in PVR

219

96

78

98

88

97

As the Council introduces the PVR in Nigeria, the experience and lessons learned from this process
will be utilized to guide similar introductory efforts for another ring type, a long-acting combined
hormonal vaginal ring developed for contraceptive protection outside the breastfeeding period. As
shown in Table 8, over 95% of respondents, irrespective of sector, were interested in this ring. In the
bidding game for this ring, consumers in the public (65%), private nonprofit (77%), and private
commercial (75%) sectors expressed willingness to pay for this one-year CVR at the starter price. With
price increases, although there is a decline in the willingness to pay, the demand is still high; for
example, at a 20% increase over the starter price, 45% of public sector consumers and 55% of
private sector consumers would still be willing to pay for the product.

FIGURE 7 CONSUMER DEMAND CURVE FOR ONE-YEAR CVR—PUBLIC SECTOR
% respondents…
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Demand (%WTP)
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100% 98% 97%
94% 94%
73% 72% 70%
68%
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20
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0%

0

n=219

Maximum Price (Naira)

As can be seen in Figure 7, demand for the one-year CVR in the public sector remains high with
incremental prices up to N1,000 or US$6 (68%). Even at N1,500 or US$9, 27% of the consumers
expressed willingness to buy the one-year ring. In the private nonprofit sector, the demand stays high
at 84% even at a price of N1,500 (Figure 8), while 81% of consumers in the private commercial
sector would buy the one-year CVR at the same N1,500 (Figure 9). The analysis indicates that N1,000
is the inflection point in the demand curves of all sectors for the investigational one-year CVR. It is
clear that consumers are willing to pay for the one-year CVR at much higher prices than they would for
the PVR. One reason for this preferential demand for the investigational one-year CVR at a much
higher price could be the ring’s duration of action, which is one year as opposed to the PVR which
lasts for three months.
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FIGURE 8 CONSUMER DEMAND FOR ONE-YEAR CVR—PRIVATE NONPROFIT SECTOR
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FIGURE 9 CONSUMER DEMAND FOR ONE-YEAR CVR—PRIVATE COMMERCIAL SECTOR
% respondents WTP
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Consumers’ perception of the PVR is generally encouraging (Table 9). Many believe it is a good
innovation for breastfeeding women who want to use a modern method of contraception for spacing.
Many would recommend it to others because they perceive that it has little or no side effects.
However, some women feel that the PVR is invasive because of its vaginal use and others feel that
the size of the PVR is unappealing. It is to be noted that responses on size and shape are typical
when respondents are asked about perceptions without having had any experience using the ring.12

12

Women who had used the ring for another study reported that size, color, and texture were not important determinants; with
use, responses on all of these three attributes improved over time.
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TABLE 9 Consumer comments on PVR and one-year CVR by sector
Sector

Comments on PVR

Comments on One-Year CVR

Public

“The product is okay/good. It is affordable.”
“It is easy to use.”
“I am skeptical about the product.”
“Maintain the quality of the product.”
“Make it good, effective, or improve the quality (size,
packaging, duration).”

“Product is okay. Make it available.”
“It is easy to use.”
“I like the product. I recommend it to women.”
“Prefer other products. Will give it a trial, because
of duration (of use).”

Private
Nonprofit

“The product is good.”
“Make it affordable.”
“Make it available.”
“I am willing to buy it.”

“Product is okay/good.”
“Make it affordable.”
“Maintain the quality of the product. I like the
product and will recommend it to women.”

Private
Commercial

“Make it easy to use and provide assistance for use.”
“It is invasive.”
“It is safe, with little or no side effects.”

“I like the product. I will recommend it to women.”
“There is a need to create more awareness
among women.”

PROVIDER SURVEY
Provider Profile by Sector
TABLE 10 Provider profile by sector
Sector
Public

Profile (Job Titles, Education, Responsibilities Regarding Family Planning)
Job titles: CHEWs/CHOs; gynecologists; managers; matrons, nurses
Education: Secondary/College/Graduate; Specialists
Responsibilities regarding FP: Consultation on FP information; counseling and servicing on FP methods;
counseling and guidance; teaching about FP

Private

Job title: CHEWs; CHOs; nurses

Nonprofit

Education: College
Responsibilities regarding FP: FP Counseling; provide FP commodity to clients

Private

Job title: Administrative officers; attendants; auxiliary nurses; CHEWs; laboratory attendants; laboratory

Commercial

technicians; medical directors, medical officers, managers; matrons, nurses, midwives; pharmacists;
resident doctors; sales representatives
Education: Secondary/College/Graduate
Responsibilities regarding FP: Counseling and dispensing; counseling and treatment; counseling and
administering drugs; selling contraceptive commodities; creating awareness about FP; help clients make the
right method choices; conduct deliveries; provide FP information and services
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A range of providers was interviewed across all sectors. All interviewed providers were involved in
some aspect of family planning service delivery, including counseling, commodity provision,
education, and administration (Table 10). Providers ranged from gynecologists and obstetricians, to
nurses/midwives, Community Health Extension Workers (CHEWs), Community Health Officers (CHOs),
and other administrative and supportive staff. Although there are more gynecologists in the public
sector than in other sectors, every sector has the necessary mix of skilled personnel to provide the
range of methods available in the country.

Sector Qualitative Comments
TABLE 11 Provider comments on the PVR and one-year CVR by sector
Sector

Comments on PVR

Public

“It is a welcome development.”
“It will be easy to use, prevent taking daily pill.”
“The price should be subsidized in rural areas.”
“The size of the ring is too big.”

“I am looking forward to seeing the long-acting
ring.”
“This will be good as it is for all women.”
“It will replace vaginal cap (not in stock).”

Comments on One-Year CVR

Private
Nonprofit

“Good for spacing, if it works as said.”
“Training of health workers should be done.”

“We will like it if there is training.”

Private
Commercial

“Reduce the size to make it comfortable.”
“I am concerned about its reliability.”
“It is good and convenient if tested and proven.”
“It is hard and big, may scare the users.”
“It will need demonstration for usage.”
“It is big to stay at posterior fornix of the vagina.”

“I will appreciate it with affordable price.”
“It gives opportunity to try new FP method.”
“I like the idea of self-administration.”
“Its longevity (one year) will be a better idea.”
“It will likely interfere with intercourse.”

As was the case with clients’ perceptions, providers also expressed feelings about the PVR and the
one-year CVR (Table 11). While the majority of comments on the rings were positive, some expressed
reservations. For example, while many providers felt that self-use and easy reversibility of the method
were positive features, they also reported concerns about the “big size” and the ring’s potential for
interfering with intercourse. As found in other studies, most of these negative perceptions would likely
fade away after the rings are introduced and used. However, as first impression matters, education
and support for family planning providers is essential during the introductory phase. Suffice to say
that vaginal rings should be introduced in phases, starting with providers at urban and peri-urban
public facilities, and gradually scaling up to the urban private sector.
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PROCURER SURVEY
Procurer Profile by Sector
TABLE 12 Provider profile by sector
Sector
Public

Private NonProfit

Private
Commercial

Profile (Job Titles, Responsibilities, Names of Organizations, Products Procured)
Job titles: Chief pharmacist; chief regulatory officer; clinician; director of pharmaceutical services; logistics
officer; logistics manager
Responsibilities regarding FP: Daily stock-taking of RH commodities and ensuring that commodities are
available; logistic officer in charge of procurement and management; provision of FP services to clients;
regulation and registration of FP devices; stock management and reporting and distribution to states;
supervising and coordinating product regulation at NAFDAC
Name of organizations: National Essential Drugs programs; Catholic Relief Services; FMoH; NAFDAC;
National Hospital Abuja
Products procured: Male condoms; IUDs; combined oral contraceptives; implants; EC pills; CycleBeads
Job titles: Nursing officers/midwives, assistant managers, clinical director; clinical service manager; country
director DKT; director of procurement; enterprise fund manager; logistics advisor; logistics and commodity
program manager; national coordinator, CiSFP; program officer for service delivery; program officer for
advocacy; state coordinator, CiSFP; RH coordinator, CRS; national program specialist, FP
Responsibilities regarding FP: Advising the government and providing technical support for quantification;
coordinating FP services for the states; distributing LNG-IUS to FP service facilities; quality assurance and
monitoring; FP needs identification and requisition for communities; advocating for FP interventions with
local and international organizations; marketing and distribution of contraceptive products; social marketing
for FP commodities; stock management and requisition; supporting quantification and supply-chain
procedures for the government; galvanizing actions with civil society organizations to support FP
Name of organizations: CiSFP; CRS; DKT International; FHI 360; JSI; Marie Stopes–Nigeria; MSI; PPFA;
Rotary Club; SFH; UNFPA; USAID
Products procured: Female condoms; implants; LNG-IUS; male condoms; EC pills; implants; injectables;
combined oral contraceptives; IUDs; Sayana Press; CycleBeads
Job titles: Pharmacist; pharmacy manager; supplementary pharmacist
Responsibilities regarding FP: Dispensing and referring couples for FP services; introducing available FP
methods to clients and counseling on method-administration processes
Name of organizations: Anijah Pharmacy; Bez Pharmacy and Stores Nigeria; Indumex Pharmacy; Rabina
Pharmacy
Product procured: Condoms; EC pills; injectables; combined oral contraceptives

A wide range of procurers were interviewed including policymakers, regulators, representatives of
local and international nongovernmental organizations, community stakeholders, social franchising
organizations, civil societies, local and international donors, and representatives of government
agencies. Across both the public and private sector, all registered contraceptive commodities in
Nigeria are being procured and distributed (Table 12).
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Procurer Priorities (Process, Quality Control, Logistics) by Sector
TABLE 13 Procurer priorities by sector
Domain

Public Sector

Private Nonprofit Sector

Private Commercial Sector

Procurement
Process

“My boss does the
quantification, forecasting, and
planning before mandating to
UNFPA who procures the
commodities. Procurement is
made by direct purchase from
the manufacturers.”

“We used a form supplied from
London to enable us do forecasting
based on usage rate.”
“We also use ‘basket fund’ for
procurement, which is donorcontributed.”
“JSI supports, coordinates,
requests from state offices, and
places order (for procurement)
from the manufacturers, while DKT
International procures directly from
the manufacturers.”

“Purchases are made from Society for
Family Health or DKT International and
wholesalers through a third-party
agreement.”

Price Setting

“It is mainly based on the
supplier’s quotation.
Manufacturers set prices, which
are then negotiated. UNFPA
handles the negotiation with the
manufacturers.”

“We ask for a quotation from
“Prices are set by producers and agents.
vendors at the central and national We do not set prices.”
level. Based on negotiation with
the manufacturers and in check
with other social-marketing
organizations such as DKT and the
prevailing market situation, we
send a tender through a
competitive process.”

Quality Control

“It is done in collaboration with
NAFDAC and complying with
WHO PQ, and determined
through the Essential Medicines
List (EML) committee. The quality
specification can be found in the
EML. We test the product based
on the manufacturers’
instruction.”

“It is based on WHO PQ and EML of
Nigeria. Company preshipment
assessment is conducted following
WHO guidelines. NAFDAC also
inspects and regulates on arrival.
Organizations have their own
guidelines that are drafted and
adopted from WHO guidelines. So,
quality control is done by the
manufacturers, local regulator, and
procuring organizations.

“We check for expiration dates and only
the drugs on the EML are included. We
also rely on the reputation of suppliers,
e.g. SFH and DKT, and on
recommendations of agents or
manufacturers.”

NAFDAC = National Agency for Food and Drug Administration and Control. PQ = Prequalification.

Nigeria has a robust system in place for contraceptive procurement, pricing, and quality control
across the public, private nonprofit, and private commercial sectors (Table 13). Because UNFPA
procures commodities for the public system, pricing and quality control are done according to
international standards. The processes for the private nonprofit system are based on the World
Health Organization (WHO) standard and pricing is done through a very competitive process. The
private commercial sector predominantly relies on a supply and verification system of social
franchising organizations such as SFH and DKT International. Even though robust mechanisms and
processes are in place, there are often reported cases of substandard and counterfeited reproductive
health and FP commodities, highlighting the importance of continuous vigilance.
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TABLE 14 Procurer comments on the PVR and one-year CVR by sector
Sector

Comments on PVR

Comments on One-Year CVR

Public

“Good method for breastfeeding women.”
“It has to be registered first. Some women would use it.
This will promote healthy child spacing.”

“It will add to the available methods mix.”
“It will prevent unwanted pregnancies and
reduce illegal abortion. With this, most ladies
can complete their education.”

Private
Nonprofit

“It [procurement and use] depends on the government. The
government determines what is procured.”
“If it is really as you have described it, it looks as if it would
be liked by most spouses.”

“[For procurement and availability], it is the
same with the PVR: It depends on government
(willingness). It will help bring down the cases
of unwanted pregnancies.”

Private
Commercial

“If the public likes and asks for it, and it is not complicated
… it will certainly be of high demand for child spacing.”

“Girls would like and use it. It will help our
women. Removal at users’ convenience;
women will like it.”

Procurers are unanimous on the utility and value-adding potential of the PVR and the one-year CVR
when eventually registered and introduced in the country (Table 14). The rings would add to the mix
of contraceptive methods in the country and are generally perceived as capable of improving the
uptake of contraceptives (Ross and Stover 2013) and thus preventing unwanted pregnancies and
enhancing healthy child spacing. However, for this to happen, according to the views of many
procurers, the government should show interest by playing a leading role in contraceptive
procurement and distribution.
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Conclusion
Contraceptive services and commodities are available free of charge at public health facilities in
Nigeria. However, public facilities have frequent stock-outs and hence the private sector accounts for
more than 60% of contraceptive provision in the country in both rural and urban settings. The
government of Nigeria has committed to a goal of reaching a CPR of 36% by 2018 and has outlined
an ambitious strategy for achieving this goal. The introduction of new contraceptives to enhance
contraceptive choice and address unmet need for family planning is part of the strategy. However,
new product introduction often suffers from a lack of available market research and relies on
hypothetical approaches to gauge consumer demand. As a new product in sub-Saharan Africa, similar
challenges will be faced by the PVR. To prepare for and facilitate eventual introduction into Nigeria,
we undertook this study to assess consumers’ “Willingness to Pay,” providers’ “Willingness to
Provide,” and procurers’ “Willingness to Procure.” Findings were generated on all three aspects and
are listed below.


Prospective consumers, providers, and procurers expressed support and interest in
contraceptive vaginal rings. Frequently expressed opinions were that the PVR (and the oneyear CVR) is a welcome development that would add value to the postpartum family planning
landscape, broaden contraceptive options for women, enhance child spacing, and prevent
unintended pregnancies.



Consumers are willing to pay for the PVR irrespective of the sector through which they access
contraceptive commodities. At a price point of US$1.7 (N300), more than 75% of consumers
are willing to pay for the PVR in the public, private nonprofit, and private commercial sectors.
Willingness to pay in the public sector declines at prices over N300. However, in the private
sector (nonprofit and commercial), a significant proportion of women are willing to purchase
the PVR at higher prices.



Although the price of the PVR is a determinant of consumer demand, respondents also
indicated other factors such as the desire to avoid unintended pregnancy and the ability to
use modern contraceptives as being important to their decision-making. The importance of
wanting to avoid unwanted pregnancy is clearly reflected in the market as evidenced by the
high median cost of EC pills (US$27) in the private sector.



Consumers are willing to pay for the one-year CVR as well. The analysis indicates a feasible
price point of US$9 (N1,000) with a demonstrated willingness to pay across all three sectors.
At this price, more than 65% are willing to pay in the public sector and more than 80% in the
private nonprofit and commercial sectors.



The potential for innovative pricing mechanisms, especially for public-sector consumers will
need to be explored. The mechanism would leverage existing government subsidies so that
consumers pay a small portion of the price with financing covering the rest.



The active role of the private sector in FP provision is indicative of the possibility of utilizing a
vibrant total market for the introduction of the PVR to serve its customer segments based on
their levels of willingness to pay.
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Providers across all three sectors indicated the importance of including the PVR and one-year
CVR in the method mix. Their responses also highlighted the importance of orientation and
education for potential providers to ensure successful integration of the rings when
eventually registered.



The procurement, pricing, and quality-assurance systems are robust in Nigeria. The PVR (and
the one-year CVR), when introduced, could easily feed into the existing structures and obviate
the need for establishing parallel procurement, pricing, and quality-assurance systems.

Through this study we have gained better insight into the socioeconomic determinants of product
use, including the consumer’s willingness to pay and also the priorities that drive the important
stakeholders—providers and procurers. In terms of utilization, the results generated will inform and
guide next steps about product introduction. Specifically, the findings of this study will be integrated
with results from a market-segmentation exercise conducted earlier to develop a pricing model for
the PVR. The price will reflect not only the cost of goods and cost of product introduction (training,
educational material, marketing and branding, demand creation), but also the benefits to the health
system (e.g., limited need for infrastructure and equipment, potential for multiple service outlets and
health cadres). The results will also be useful to refine PVR market segmentation and tailor specific
strategies for product introduction, including innovative financing approaches.
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